GALECTIN THERAPEUTICS INC Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Galectin Therapeutics Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Galectin Therapeutics Inc Return On Equity for the quarter ending September 30, 2024 was 57.6 %, a 36.5% decline year-over-year.
  • Galectin Therapeutics Inc annual Return On Equity for 2023 was 77.6 %, a 58.6% decline from 2022.
  • Galectin Therapeutics Inc annual Return On Equity for 2022 was 187 %.
  • Galectin Therapeutics Inc annual Return On Equity for 2021 was -303 %, a 315% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 57.6 -33.2 -36.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 65.3 -37.5 -36.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 68.3 -67.1 -49.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 77.6 -110 -58.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 90.8 -204 -69.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 103 -756 -88% Apr 1, 2023 Jun 30, 2023
Q1 2023 135 +994 Jan 1, 2023 Mar 31, 2023
Q4 2022 187 +490 Oct 1, 2022 Dec 31, 2022
Q3 2022 295 +496 Jul 1, 2022 Sep 30, 2022
Q2 2022 858 +994 Apr 1, 2022 Jun 30, 2022
Q1 2022 -859 -758 -751% Jan 1, 2022 Mar 31, 2022
Q4 2021 -303 -230 -315% Oct 1, 2021 Dec 31, 2021
Q3 2021 -201 -146 -264% Jul 1, 2021 Sep 30, 2021
Q2 2021 -136 -93.9 -224% Apr 1, 2021 Jun 30, 2021
Q1 2021 -101 -69.2 -218% Jan 1, 2021 Mar 31, 2021
Q4 2020 -73 -36.7 -101% Oct 1, 2020 Dec 31, 2020
Q3 2020 -55.3 -13.8 -33.2% Jul 1, 2020 Sep 30, 2020
Q2 2020 -41.9 +24.4 +36.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -31.7 +156 +83.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 -36.3 +224 +86% Oct 1, 2019 Dec 31, 2019
Q3 2019 -41.5 +296 +87.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -66.3 +568 +89.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -188 +957 +83.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -260 +263 +50.3% Oct 1, 2018 Dec 31, 2018
Q3 2018 -337 -19.9 -6.27% Jul 1, 2018 Sep 30, 2018
Q2 2018 -634 -406 -178% Apr 1, 2018 Jun 30, 2018
Q1 2018 -1.14K -927 -426% Jan 1, 2018 Mar 31, 2018
Q4 2017 -523 -311 -147% Oct 1, 2017 Dec 31, 2017
Q3 2017 -317 -139 -78.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -228 -47.7 -26.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -218 -73.8 -51.3% Jan 1, 2017 Mar 31, 2017
Q4 2016 -211 -98 -86.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -178 -74.7 -72.1% Jul 1, 2016 Sep 30, 2016
Q2 2016 -180 -101 -126% Apr 1, 2016 Jun 30, 2016
Q1 2016 -144 -76.3 -113% Jan 1, 2016 Mar 31, 2016
Q4 2015 -113 -49.3 -76.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 -104 -28 -37.1% Jul 1, 2015 Sep 30, 2015
Q2 2015 -79.5 +25.4 +24.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 -67.4 +133 +66.3% Jan 1, 2015 Mar 31, 2015
Q4 2014 -64.2 -3.66K -102% Oct 1, 2014 Dec 31, 2014
Q3 2014 -75.5 -2.89K -103% Jul 1, 2014 Sep 30, 2014
Q2 2014 -105 +44.5K +99.8% Apr 1, 2014 Jun 30, 2014
Q1 2014 -200 +340 +62.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 3.6K +3.84K Oct 1, 2013 Dec 31, 2013
Q3 2013 2.81K +3.15K Jul 1, 2013 Sep 30, 2013
Q2 2013 -44.6K -44.2K -11516% Apr 1, 2013 Jun 30, 2013
Q1 2013 -540 +111 +17% Jan 1, 2013 Mar 31, 2013
Q4 2012 -243 Oct 1, 2012 Dec 31, 2012
Q3 2012 -337 Jul 1, 2012 Sep 30, 2012
Q2 2012 -384 Mar 29, 2012 Jun 30, 2012
Q1 2012 -651 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.